{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:06:42Z","timestamp":1787771202495,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T00:00:00Z","timestamp":1328486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T00:00:00Z","timestamp":1328486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/leu.2012.29","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T02:39:44Z","timestamp":1328495984000},"page":"1654-1662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection"],"prefix":"10.1038","volume":"26","author":[{"given":"J","family":"Peveling-Oberhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Crisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lucioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Arcaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rattotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Piiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-P","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Paulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-L","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,6]]},"reference":[{"key":"BFleu201229_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL, Pileri SA, Stein H, Thiele J et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008."},{"key":"BFleu201229_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.humpath.2009.09.007","volume":"41","author":"SD Dufresne","year":"2010","unstructured":"Dufresne SD, Felgar RE, Sargent RL, Surti U, Gollin SM, McPhail ED et al. Defining the borders of splenic marginal zone lymphoma: a multiparameter study. Hum Pathol 2010; 41: 540\u2013551.","journal-title":"Hum Pathol"},{"key":"BFleu201229_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2141.2008.07301.x","volume":"143","author":"M Dungarwalla","year":"2008","unstructured":"Dungarwalla M, Appiah-Cubi S, Kulkarni S, Saso R, Wotherspoon A, Osuji N et al. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis. Br J Haematol 2008; 143: 71\u201374.","journal-title":"Br J Haematol"},{"key":"BFleu201229_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522\u2013531.","journal-title":"Nat Rev Genet"},{"key":"BFleu201229_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857\u2013866.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201229_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2009.11.036","volume":"398","author":"X Liu","year":"2010","unstructured":"Liu X, Wang T, Wakita T, Yang W . Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 2010; 398: 57\u201367.","journal-title":"Virology"},{"key":"BFleu201229_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/hep.22158","volume":"47","author":"H Varnholt","year":"2008","unstructured":"Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47: 1223\u20131232.","journal-title":"Hepatology"},{"key":"BFleu201229_CR8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/gut.2009.192088","volume":"59","author":"T Durand","year":"2010","unstructured":"Durand T, Di Liberto G, Colman H, Cammas A, Boni S, Marcellin P et al. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes. Gut 2010; 59: 934\u2013942.","journal-title":"Gut"},{"key":"BFleu201229_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7326\/0003-4819-116-2-97","volume":"116","author":"RG Simonetti","year":"1992","unstructured":"Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97\u2013102.","journal-title":"Ann Intern Med"},{"key":"BFleu201229_CR10","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","volume":"82","author":"C Ferri","year":"1993","unstructured":"Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701\u20133704.","journal-title":"Blood"},{"key":"BFleu201229_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","volume":"102","author":"A Mele","year":"2003","unstructured":"Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996\u2013999.","journal-title":"Blood"},{"key":"BFleu201229_CR12","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V87.10.4296.bloodjournal87104296","volume":"87","author":"F Silvestri","year":"1996","unstructured":"Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296\u20134301.","journal-title":"Blood"},{"key":"BFleu201229_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","volume":"6","author":"S de Sanjose","year":"2008","unstructured":"de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451\u2013458.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFleu201229_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/jcp.2010.076810","volume":"63","author":"SS Chuang","year":"2010","unstructured":"Chuang SS, Liao YL, Chang ST, Hsieh YC, Kuo SY, Lu CL et al. Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas. J Clin Pathol 2010; 63: 595\u2013598.","journal-title":"J Clin Pathol"},{"key":"BFleu201229_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/157488410791110751","volume":"5","author":"L Arcaini","year":"2010","unstructured":"Arcaini L, Bruno R . Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. Curr Clin Pharmacol 2010; 5: 74\u201381.","journal-title":"Curr Clin Pharmacol"},{"key":"BFleu201229_CR16","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/sj.leu.2404853","volume":"21","author":"E Ruiz-Ballesteros","year":"2007","unstructured":"Ruiz-Ballesteros E, Mollejo M, Mateo M, Algara P, Martinez P, Piris MA . MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 2007; 21: 2547\u20132549.","journal-title":"Leukemia"},{"key":"BFleu201229_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2141.2011.08848.x","volume":"156","author":"M Bouteloup","year":"2011","unstructured":"Bouteloup M, Verney A, Rachinel N, Callet-Bauchu E, Ffrench M, Coiffier B et al. MicroRNA expression profile in splenic marginal zone lymphoma. Br J Haematol 2011; 156: 279\u2013281.","journal-title":"Br J Haematol"},{"key":"BFleu201229_CR18","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1182\/blood-2010-05-285403","volume":"116","author":"DD Jima","year":"2010","unstructured":"Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010; 116: e118\u2013e127.","journal-title":"Blood"},{"key":"BFleu201229_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/labinvest.2009.26","volume":"89","author":"LP Tan","year":"2009","unstructured":"Tan LP, Wang M, Robertus JL, Schakel RN, Gibcus JH, Diepstra A et al. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab Invest 2009; 89: 708\u2013716.","journal-title":"Lab Invest"},{"key":"BFleu201229_CR20","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing. R Development Core Team: Vienna, Austria, 2005."},{"key":"BFleu201229_CR21","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.","journal-title":"Genome Biol"},{"key":"BFleu201229_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP . A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185\u2013193.","journal-title":"Bioinformatics"},{"key":"BFleu201229_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/00031305.1986.10475419","volume":"40","author":"GE Dallal","year":"1986","unstructured":"Dallal GE, Leland W . An analytic approximation to the distribution of lilliefors's test statistic for normality. Am Stat 1986; 40: 294\u2013296.","journal-title":"Am Stat"},{"key":"BFleu201229_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57: 289\u2013300.","journal-title":"J R Statist Soc B"},{"key":"BFleu201229_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","volume":"106","author":"E Ruiz-Ballesteros","year":"2005","unstructured":"Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 2005; 106: 1831\u20131838.","journal-title":"Blood"},{"key":"BFleu201229_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N . miRWalk-database: prediction of possible miRNA binding sites by \u2018walking\u2019 the genes of three genomes. J Biomed Inform 2011; 44: 839\u2013847.","journal-title":"J Biomed Inform"},{"key":"BFleu201229_CR27","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","volume":"2","author":"B John","year":"2004","unstructured":"John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS . Human MicroRNA targets. PLoS Biol 2004; 2: e363.","journal-title":"PLoS Biol"},{"key":"BFleu201229_CR28","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ng2135","volume":"39","author":"M Kertesz","year":"2007","unstructured":"Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E . The role of site accessibility in microRNA target recognition. Nat Genet 2007; 39: 1278\u20131284.","journal-title":"Nat Genet"},{"key":"BFleu201229_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495\u2013500.","journal-title":"Nat Genet"},{"key":"BFleu201229_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15\u201320.","journal-title":"Cell"},{"key":"BFleu201229_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1261\/rna.5248604","volume":"10","author":"M Rehmsmeier","year":"2004","unstructured":"Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R . Fast and effective prediction of microRNA\/target duplexes. RNA 2004; 10: 1507\u20131517.","journal-title":"RNA"},{"key":"BFleu201229_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.leu.2405068","volume":"22","author":"E Matutes","year":"2008","unstructured":"Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 2008; 22: 487\u2013495.","journal-title":"Leukemia"},{"key":"BFleu201229_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","volume":"142","author":"A Roehle","year":"2008","unstructured":"Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 2008; 142: 732\u2013744.","journal-title":"Br J Haematol"},{"key":"BFleu201229_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajh.21667","volume":"85","author":"G Cammarata","year":"2010","unstructured":"Cammarata G, Augugliaro L, Salemi D, Agueli C, La Rosa M, Dagnino L et al. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Am J Hematol 2010; 85: 331\u2013339.","journal-title":"Am J Hematol"},{"key":"BFleu201229_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/path.1825","volume":"207","author":"J Kluiver","year":"2005","unstructured":"Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243\u2013249.","journal-title":"J Pathol"},{"key":"BFleu201229_CR36","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ijc.22800","volume":"121","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156\u20131161.","journal-title":"Int J Cancer"},{"key":"BFleu201229_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"PP Medina","year":"2010","unstructured":"Medina PP, Nolde M, Slack FJ . OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86\u201390.","journal-title":"Nature"},{"key":"BFleu201229_CR38","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1074\/jbc.M110.177063","volume":"286","author":"RC Thompson","year":"2011","unstructured":"Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD . NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155\/PU.1 pathway. J Biol Chem 2011; 286: 1675\u20131682.","journal-title":"J Biol Chem"},{"key":"BFleu201229_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ijc.25320","volume":"127","author":"L Jiang","year":"2010","unstructured":"Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 2010; 127: 505\u2013512.","journal-title":"Int J Cancer"},{"key":"BFleu201229_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.lfs.2009.12.002","volume":"86","author":"L Liu","year":"2010","unstructured":"Liu L, Jiang Y, Zhang H, Greenlee AR, Han Z . Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Life Sci 2010; 86: 192\u2013198.","journal-title":"Life Sci"},{"key":"BFleu201229_CR41","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","volume":"117","author":"A Rinaldi","year":"2011","unstructured":"Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 2011; 117: 1595\u20131604.","journal-title":"Blood"},{"key":"BFleu201229_CR42","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","volume":"116","author":"M Salido","year":"2010","unstructured":"Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 2010; 116: 1479\u20131488.","journal-title":"Blood"},{"key":"BFleu201229_CR43","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C et al. Alteration of BIRC3 and multiple other NF-kappaB pathway genes in splenic marginal zone lymphoma. Blood 2011; 118: 4930\u20134934.","journal-title":"Blood"},{"key":"BFleu201229_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","volume":"3","author":"X Ma","year":"2011","unstructured":"Ma X, Becker Buscaglia LE, Barker JR, Li Y . MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011; 3: 159\u2013166.","journal-title":"J Mol Cell Biol"},{"key":"BFleu201229_CR45","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/labinvest.2010.126","volume":"90","author":"RT Marquez","year":"2010","unstructured":"Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 2010; 90: 1727\u20131736.","journal-title":"Lab Invest"},{"key":"BFleu201229_CR46","doi-asserted-by":"publisher","first-page":"e26971","DOI":"10.1371\/journal.pone.0026971","volume":"6","author":"V Bihrer","year":"2011","unstructured":"Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J et al. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 2011; 6: e26971.","journal-title":"PLoS One"},{"key":"BFleu201229_CR47","doi-asserted-by":"publisher","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","volume":"6","author":"S Cermelli","year":"2011","unstructured":"Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L . Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011; 6: e23937.","journal-title":"PLoS One"},{"key":"BFleu201229_CR48","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","volume":"25","author":"Y Murakami","year":"2006","unstructured":"Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537\u20132545.","journal-title":"Oncogene"},{"key":"BFleu201229_CR49","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/hep.22749","volume":"49","author":"S Ura","year":"2009","unstructured":"Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098\u20131112.","journal-title":"Hepatology"},{"key":"BFleu201229_CR50","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","volume":"361","author":"J Ji","year":"2009","unstructured":"Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437\u20131447.","journal-title":"N Engl J Med"},{"key":"BFleu201229_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00432-010-0918-4","volume":"137","author":"W Gao","year":"2010","unstructured":"Gao W, Shen H, Liu L, Xu J, Shu Y . MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 2010; 137: 557\u2013566.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFleu201229_CR52","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","volume":"113","author":"R Malumbres","year":"2009","unstructured":"Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754\u20133764.","journal-title":"Blood"},{"key":"BFleu201229_CR53","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/j.1582-4934.2010.01170.x","volume":"15","author":"YL Ma","year":"2010","unstructured":"Ma YL, Zhang P, Wang F, Moyer MP, Yang JJ, Liu ZH et al. Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b. J Cell Mol Med 2010; 15: 1941\u20131954.","journal-title":"J Cell Mol Med"},{"key":"BFleu201229_CR54","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","volume":"125","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R . Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723\u20131732.","journal-title":"Gastroenterology"},{"key":"BFleu201229_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.20205","volume":"111","author":"E Negri","year":"2004","unstructured":"Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S . B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004; 111: 1\u20138.","journal-title":"Int J Cancer"},{"key":"BFleu201229_CR56","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.bbrc.2005.12.228","volume":"341","author":"J Chen","year":"2006","unstructured":"Chen J, Li L, Zhang Y, Yang H, Wei Y, Zhang L et al. Interaction of Pin1 with Nek6 and characterization of their expression correlation in Chinese hepatocellular carcinoma patients. Biochem Biophys Res Commun 2006; 341: 1059\u20131065.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu201229_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1158\/1541-7786.MCR-09-0291","volume":"8","author":"R Nassirpour","year":"2010","unstructured":"Nassirpour R, Shao L, Flanagan P, Abrams T, Jallal B, Smeal T et al. Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target. Mol Cancer Res 2010; 8: 717\u2013728.","journal-title":"Mol Cancer Res"},{"key":"BFleu201229_CR58","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/sj.bjc.6604682","volume":"99","author":"A Takeno","year":"2008","unstructured":"Takeno A, Takemasa I, Doki Y, Yamasaki M, Miyata H, Takiguchi S et al. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer 2008; 99: 1307\u20131315.","journal-title":"Br J Cancer"},{"key":"BFleu201229_CR59","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.4161\/cc.9.23.14059","volume":"9","author":"HJ Jee","year":"2010","unstructured":"Jee HJ, Kim AJ, Song N, Kim HJ, Kim M, Koh H et al. Nek6 overexpression antagonizes p53-induced senescence in human cancer cells. Cell Cycle 2010; 9: 4703\u20134710.","journal-title":"Cell Cycle"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201229","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T20:28:16Z","timestamp":1713472096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,6]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFleu201229"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.29","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,6]]},"assertion":[{"value":"28 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}